127 results
Lifestyle Therapy for Diabetes - AACE 2018 Guidelines

#Lifestyle #Modifications #Therapy #Diabetes #DM2 #AACE #2018 #Guidelines #Management
Diabetes - AACE 2018 ... #Lifestyle #Modifications ... Diabetes #DM2 #AACE #2018
ACC/AHA Statin Guidelines - 2013 vs 2017

In 2013 the ACC/AHA guidelines drastically changed the way we
Statin Guidelines - 2013 ... vs 2017 In 2013 ... In 2016 and 2017 ... #2017 #Statin # ... PrimaryCare #Goals #Comparison
Comparison of Chronic Asthma and COPD Management 2016

- Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/

#Asthma
Comparison of Chronic ... COPD Management 2016 ... #Asthma #COPD #Comparison ... #Chronic #Treatment
How does the 2019 Novel Coronavirus (nCoV2019) compare to Ebola, SARS, MERS? Cases and Deaths
Weighing diseases
How does the 2019 ... Congo, Uganda: (2018 ... MERS coronavirus (2012 ... nCoV (December 2019 ... #Coronavirus #comparison
COPD assessment and classification as proposed by GOLD 2001, 2006, 2011 and 2017 Reports. For further
GOLD 2001, 2006, 2011 ... and 2017 Reports ... GOLD2017 #History #Comparison
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Tapering DMARDs - Treatment ... Modification - ... Guidelines #management #treatment
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Update of the 2013 ... ACCAHA2017 #cardiology #treatment
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
anesthesiology #treatment ... amp; Mishra, R. (2015 ... Melemeni, A. (2010 ... amp; Shetti, A. (2013
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
diagnosis #management #treatment ... (2018). ... Johannsen, S. (2014 ... Diagnosis and treatment ... ; Stowell, K. (2015
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Insulin Lifestyle modifications ... medications #table #comparison